Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
BMC Womens Health ; 24(1): 341, 2024 Jun 14.
Artigo em Inglês | MEDLINE | ID: mdl-38877419

RESUMO

BACKGROUND: This cross-sectional study aims to explore whether there exists an interaction between selenium and menopause concerning type 2 diabetes (T2D) prevalence and its related indicators such as fasting blood glucose (FBG) and homeostasis model assessment of insulin resistance (HOMA-IR). METHODS: 150 women aged 35-60 years old were finally analyzed in this study. Multivariate linear or logistic regression modeling was conducted to explore the association of selenium and the prevalence of T2D besides its related indicators. Subgroup analyses were conducted based on menopause status to assess the potential impact on the relationship. RESULTS: In the fully adjusted model, serum selenium was positively associated with FBG (ß: 0.03, CI: 0.01-0.05) and the prevalence of T2D (OR: 1.04, CI: 1.00-1.08). After stratifying the data by menopause status, compared with the postmenopausal women group, as the serum selenium concentrations increased, the FBG concentrations were significantly higher in the premenopausal women group (p for interaction = 0.0020). CONCLUSIONS: The present study found serum selenium was positively associated with FBG and the prevalence of T2D. Furthermore, the relationship between serum selenium and FBG was different in the premenopausal and postmenopausal women. More studies are still needed in the future to verify the relationship as well as to explore the specific mechanisms.


Assuntos
Glicemia , Diabetes Mellitus Tipo 2 , Resistência à Insulina , Menopausa , Selênio , Humanos , Feminino , Selênio/sangue , Estudos Transversais , Pessoa de Meia-Idade , Glicemia/análise , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/epidemiologia , Adulto , Menopausa/sangue , Resistência à Insulina/fisiologia , Jejum/sangue , Prevalência , Pós-Menopausa/sangue , Pré-Menopausa/sangue
2.
BMC Public Health ; 24(1): 743, 2024 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-38459526

RESUMO

BACKGROUND: The association between dietary selenium(Se) intake and type 2 diabetes mellitus (T2DM) remains controversial. The present study aimed to investigate this association using data from the National Health and Nutrition Examination Survey (NHANES) database for the years 2007-2012. METHODS: Three thousand seventy three individuals aged 20 years and above were eligible for inclusion in this cross-sectional study. The average age of the participants was 50.74 years and the proportions of males and females were nearly equal (49.12% vs. 50.88%). The odds ratios (OR) of the association between dietary Se intake (log2-transformed) and T2DM were examined through the multivariate logistic regression model. Subgroup analyses were conducted based on age, sex, and thyroid autoimmunity to assess the potential impact of these variables on the relationship. Fitted smoothing curves and threshold effect analysis were conducted to describe the nonlinear relationship. RESULTS: In the fully adjusted model, a significant positive association between Se intake and T2DM was observed (OR = 1.49, 95% CI: 1.16, 1.90, p = 0.0017). After stratifying the data by age, sex, and thyroid autoimmunity, a significant positive association between Se intake and T2DM was observed in individuals under 65 years of age, males, and those with negative thyroid autoimmunity. A two-segment linear regression model was analyzed for sex stratification, revealing a threshold effect in males with an inflection point of 90.51 µg, and an inverted U-shaped relationship in females with an inflection point of 109.90 µg, respectively. CONCLUSIONS: The present study found a positive relationship between Se intake and the prevalence of T2DM. This association is particularly significant in younger individuals, males, and those with negative thyroid autoimmunity. Our results should be validated in future large prospective studies in different populations.


Assuntos
Diabetes Mellitus Tipo 2 , Selênio , Masculino , Feminino , Humanos , Pessoa de Meia-Idade , Pré-Escolar , Diabetes Mellitus Tipo 2/epidemiologia , Glândula Tireoide , Inquéritos Nutricionais , Autoimunidade , Estudos Prospectivos , Estudos Transversais
3.
Res Pract Thromb Haemost ; 5(4): e12527, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-34027293

RESUMO

INTRODUCTION: Postthrombotic syndrome (PTS) is a form of secondary chronic venous insufficiency (CVI) that occurs after deep vein thrombosis (DVT). Effective treatments for PTS are lacking. Micronized purified flavonoid fraction (MPFF) is a venoactive drug used in the treatment of CVI. OBJECTIVE: To determine whether MPFF is a good candidate to explore as a therapeutic agent for PTS. METHODS: We performed a narrative review in which we identified 14 systematic reviews, 33 randomized controlled trials, and 19 observational studies that discussed the use of MPFF in CVI, as well as studies that reported on the mechanistic action of MPFF in relation to the pathophysiology of PTS. RESULTS: MPFF targets a number of pathophysiologic components of PTS. Based on animal models and human studies investigating objective vascular and lymphatic measures, MPFF promotes venous recanalization after DVT, decreases venous remodeling and reflux, inhibits inflammatory processes, improves venous tone and stasis, improves lymphatic circulation, improves capillary hyperpermeability, and decreases tissue hypoxia. Furthermore, MPFF shows promise in improving clinical manifestations, quality of life, and objective venous parameters of CVI. Studies suggest good patient acceptability and tolerability with the use of MPFF in CVI. CONCLUSION: MPFF is a good candidate to explore as a potential therapy for PTS. Confirmatory high-quality studies are still needed to reinforce the evidence supporting the use of MPFF in CVI. Double-blind randomized controlled trials with clinical endpoints are needed to assess the clinical efficacy of MPFF in the treatment of PTS.

4.
Appl Opt ; 56(6): 1674-1681, 2017 Feb 20.
Artigo em Inglês | MEDLINE | ID: mdl-28234376

RESUMO

We experimentally demonstrate a kind of simplified Yb-doped mode-locked fiber laser with a nonlinear polarization rotation technique. In the oscillator, there are no waveplates, physical bandpass filters, or polarization controlling devices except for one polarized beam splitter and a polarization-independent isolator. In the experiment, self-started stable mode locking pulse trains are obtained with four different cavity lengths: 110 m, 66 m, 50 m, and 26 m. To make clear the mechanism of pulse formation of this kind of simplified fiber laser, the characteristics of which are called an artificial saturable absorber, are discussed and the influences of these parameters on mode locking are also analyzed.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA